Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2020-11-04 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
109年第3季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates such as 109年09月30日 (which corresponds to the third quarter of the fiscal year 2020). The presence of detailed financial statement data (assets, liabilities, equity) indicates this is a financial report rather than an announcement or certification. The data is quarterly and not a full fiscal year, suggesting it is an interim or quarterly report. The document length is 4753 characters, which is sufficient to contain substantive financial data, not just a brief announcement. Therefore, the document is best classified as an Interim / Quarterly Report (IR). Q3 2020
2020-11-04 Chinese
109年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for a company over specific periods (the first three quarters of the year 109 and 108 in the Taiwanese calendar, corresponding to 2020 and 2019). It includes line items such as common stock, capital surplus, legal reserve, undistributed earnings, retained earnings, foreign currency translation adjustments, and total equity. The data is presented in a structured format typical of financial statements or financial disclosures. The document length is 4158 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The content is consistent with a financial report for an interim period rather than a full annual report or a simple announcement. Therefore, the document is best classified as an Interim / Quarterly Report (IR). 9M 2020
2020-11-04 Chinese
公告董事會通過109年第3季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1720 生達) reporting the board's approval of the consolidated financial report for the third quarter of 2020 (109年第3季). It includes cumulative financial figures such as revenue, gross profit, net profit, earnings per share, total assets, liabilities, and equity for the quarter. The document is short (788 characters) and primarily serves as a notification of the board's approval of the quarterly financial report rather than the full report itself. It does not contain detailed financial statements or substantive analysis but summarizes key financial data. Therefore, it fits the category of an Interim / Quarterly Report (IR), as it reports comprehensive financial data for a period shorter than a full fiscal year (Q3). 9M 2020
2020-11-03 Chinese
109年09月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tabular data disclosing shareholdings of insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and related remarks. The content focuses on insider shareholding information rather than financial results, management changes, or meeting materials. There is no indication of a report publication or certification. The document is a notification of insider shareholdings, which aligns with the category of Director's Dealing (DIRS), as it reports personal share transactions or holdings by company directors and executives.
2020-10-13 Chinese
109年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed information about shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It lists their current holdings, pledged shares, and related parties' holdings. The content focuses on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of a full financial report, earnings release, or meeting materials. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is 2389 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full annual report.
2020-10-13 Chinese
109年9月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, with data for the month and year-to-date compared to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document is short (773 characters) and primarily presents financial summary data without detailed financial statements or analysis. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not fit categories like Earnings Release (ER) which typically highlight quarterly results, or Investor Presentation (IP). Given the nature of the data and the short length, this is best classified as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements and summary data that do not fit other specific categories.
2020-10-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.